CEUFX | GSIMX | CEUFX / GSIMX | |
Total Expense Ratio | 0.91 | 0.77 | 118% |
Annual Report Gross Expense Ratio | 0.91 | 0.80 | 114% |
Fund Existence | 23 years | 9 years | - |
Gain YTD | 15.242 | 15.031 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 133B | 54B | 246% |
Annual Yield % from dividends | 0.81 | 1.90 | 43% |
Returns for 1 year | 7.86 | -1.42 | -554% |
Returns for 3 years | 36.00 | 49.75 | 72% |
Returns for 5 years | 13.26 | 49.55 | 27% |
Returns for 10 years | 53.80 | N/A | - |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
ADCT | 3.40 | 0.11 | +3.34% |
ADC Therapeutics SA | |||
BIRK | 50.62 | 0.97 | +1.95% |
Birkenstock Holding plc | |||
ACGLN | 17.89 | 0.10 | +0.56% |
Arch Capital Group Ltd | |||
CDLR | 20.41 | -0.08 | -0.39% |
Cadeler A/S American Depositary Share (each representing four (4) | |||
GROV | 1.54 | -0.01 | -0.65% |
Grove Collaborative Holdings |